Strategies for preventing type II diabetes: What can be done to stem the epidemic?

Postgraduate Medicine

Volumn 101, Issue 1, 1997, Pages

  Mudaliar, Sunder R ^a   Henry, Robert R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ANOREXIGENIC AGENT; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; DEXFENFLURAMINE; FENFLURAMINE; FLUOXETINE; INSULIN; METHAMPHETAMINE; PHENTERMINE; PHENTERMINE RESIN; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

CLINICAL TRIAL; EXERCISE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHASE 3 CLINICAL TRIAL; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 1842405442     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.01.148     Document Type: Review

References (30)

1. Harris MI, Hadden WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr. Diabetes 1987;36(4):523-34
2. Harris MI. Impaired glucose tolerance in the US population. Diabetes Care 1989; 12(7):464-74
3. Lee ET, Howard BV, Savage PJ, et al. Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. Diabetes Care 1995;18(5):599-610
4. Haffner SM, Hazuda HP, Mitchell BD, et al. Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 1991;14(2):102-8
5. Fujimoto WY. Diabetes in Asian and Pacific Islander Americans. In: Harris MI, ed. Diabetes in America. National Institutes of Health, Bethesda, 1995; NIH publication No. 95-1468, pp 661-81
6. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes statistics 1995. National Institutes of Health, Bethesda, 1995; NIH publication No. 96-3926
7. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328(23):1676-85
8. Tuomilehto J, Knowler WC, Zimmet P. Primary prevention of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1992;8(4):339-53
9. Barrett-Connor E. Epidemiology, obesity, and non-insulin-dependent diabetes mellitus. Epidemiol Rev 1989;11:172-81
10. Cowie CC, Harris MI, Silverman RE, et al. Effect of multiple risk factors on differences between blacks and whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States. Am J Epidemiol 1993;137(7):719-32
11. Manson JE, Rimm EB, Stampfer MJ, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991;338(8770):774-8
12. Manson JE, Nathan DM, Krolewski AS, et al. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992;268(1):63-7
13. Helmrich SP, Ragland DR, Leung RW, et al. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991;325(3): 147-52
14. Hamman RF. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 1992;8(4):287-338
15. DeFronzo RA. Lilly lecture 1987. The triumvirate: ß-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37(6):667-87
16. Knowler WC, Narayan KM, Hanson RL, et al. Preventing non-insulin-dependent diabetes. Diabetes 1995;44(5):483-8
17. Campbell PJ, Carlson MG. Impact of obesity on insulin action in NIDDM. Diabetes 1993;42(3):405-10
18. Wing RR, Blair EH, Bononi P, et al. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 1994;17(1):30-6
19. Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 1986;35(9):990-8
20. Guy-Grand B, Apfelbaum M, Crepaldi G, et al. International trial of long-term dexfenfluramine in obesity. Lancet 1989;2(8672):1142-5
21. Maron DJ, Fair JM, Haskell WL. Saturated fat intake and insulin resistance in men with coronary artery disease. Circulation 1991;84(5):2020-7
22. Parillo M, Rivellese AA, Ciardullo AV, et al. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism 1992;41(12):1373-8
23. Kriska AM, Bennett PH. An epidemiological perspective of the relationship between physical activity and NIDDM: from activity assessment to intervention. Diabetes Metab Rev 1992;8(4):355-72
24. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmö feasibility study. Diabetologia 1991;34(12):891-8
25. Pan X, Guangwei L, Hu Y, et al. Effect of dietary and/or exercise interventions on incidence of diabetes in 530 subjects with IGT: the Da-Qing IGT and Diabetes Study. (Abstr) International Diabetes Federation Congress Program 1994:489
26. DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333(9):541-9
27. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334(9):574-9
28. Stumvoll M, Nurjhan N, Perriello G, et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333(9):550-4
29. Bressler R, Johnson D. New pharmacological approaches to therapy of NIDDM. Diabetes Care 1992;15(6):792-805
30. Nolan JJ, Ludvik B, Beerdsen P, et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994;331(18):1188-93